Hillrom

Hillrom acquired contact-free continuous monitoring technology from EarlySense for $30 million in cash, plus potential milestone payments and a portion of Hillrom's equity investment in EarlySense.

Hillrom has reached a definitive agreement to acquire Bardy Diagnostics, a provider of ambulatory cardiac monitoring technologies, for $375 million in cash plus potential milestone payments. The deal includes net operating losses valued at over $20 million.

Hillrom announced a definitive agreement to acquire Breathe Technologies, a developer of wearable non-invasive ventilation technology, for $130 million in cash. The deal is expected to close in fiscal Q4 2019.

Hillrom subsidiary Welch Allyn won a $100 million, five-year contract from the U.S. Defense Department to supply patient monitoring equipment to the Army, Navy, Air Force, Marine Corps and federal civilian agencies.